Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

ClinicalTrials.gov ID: NCT00406068

Public ClinicalTrials.gov record NCT00406068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label, Multi-center Study of the Efficacy and Safety of MCC in the Treatment of Patients With Non-muscle Invasive (Superficial) Bladder Cancer at High Risk of Progression and Who Are Refractory to BCG

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of intravesical Mycobacterial Cell Wall-DNA Complex (MCC) in patients with non-muscle invasive transitional cell carcinoma (papillary tumors and/or carcinoma in situ) of the urinary bladder at high risk of progression who are refractory to therapy with bacillus Calmette-Guerin (BCG).

Study identification

NCT ID
NCT00406068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Bioniche Life Sciences Inc.
Industry
Enrollment
129 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Jul 2011 (Actual)
Last update posted
Jul 28, 2016

2006 – 2011

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
BCG Oncology Phoenix Arizona 85032 —
San Diego Clinical Trials San Diego California 92120 —
Connecticut Urological Research at Grove Hill New Britain Connecticut 06052 —
University of Miami School of Medicine Miami Florida 33136 —
Winter Park Urology Associates P.A. Orlando Florida 32803 —
The University of Chicago Hospitals Chicago Illinois 60637 —
Welborn Clinic Evansville Indiana 47713 —
Johns Hopkins University Baltimore Maryland 21231 —
Chesapeake Urology Research Associates Towson Maryland 21204 —
Sheldon J Freedman, MD, Ltd Las Vegas Nevada 89148 —
Delaware Valley Urology, LLC-Voorhees Voorhees Township New Jersey 08043 —
Memorial Sloan Kettering Cancer Centre New York New York 10021 —
Hudson Valley Urology Poughkeepsie New York 12601 —
University of Rochester Medical Center Rochester New York 14642 —
Triangle Urology Group Pittsburgh Pennsylvania 15212 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Urology Clinics of North Texas, P.A. Dallas Texas 75231 —
M.D. Anderson Cancer Center Houston Texas 77030 —
Urology San Antonio Research, PA San Antonio Texas 78229 —
Sentara Medical Group - Urology of Virginia, PC Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00406068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00406068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →